Dermal Fillers: What They Actually Are, and Why Reversibility Is the Question That Matters Most

People talk about "fillers" as if the word named one thing. It does not. Under that single label sits a range of materials with genuinely different properties, different durations, different complication profiles, and — most importantly — different answers to one question that almost nobody asks before treatment but everybody cares about afterwards: if something goes wrong, can it be undone?

Understanding fillers means understanding that the marketing tends to compete on the wrong axis. The questions on offer are usually "how long does it last?" and "how natural does it look?" The question that actually predicts how a bad outcome plays out is reversibility — and it deserves to be near the front of any clear-eyed discussion.

What fillers are for, and the main types

Dermal fillers add volume. Where botulinum toxin relaxes muscles to soften movement lines, fillers physically fill — restoring volume lost to ageing, smoothing static folds, or reshaping features. The major categories differ in what they are made of.

Hyaluronic acid (HA) fillers are the most widely used. Hyaluronic acid is a substance the body already makes, and these fillers add temporary volume that the body gradually breaks down over months to a couple of years. Crucially, they can be dissolved on demand with an enzyme called hyaluronidase.

Then there are the longer-lasting and biostimulatory materials — calcium hydroxylapatite, poly-L-lactic acid, and others — which last longer and, in the biostimulatory cases, work partly by prompting the body to make its own collagen. And at the far end sit permanent or semi-permanent fillers, designed not to break down at all.

These are not interchangeable. They differ in how they feel, how long they last, what they are suited to, and how their complications behave.

Why reversibility is the decisive property

Here is the distinction that ought to be central and usually is not. Hyaluronic acid fillers are reversible. If the aesthetic result is wrong, if a lump forms, or — most importantly — if a vascular complication develops, hyaluronidase can dissolve the product, often quickly. That single property is a profound safety advantage. It means that the worst filler complication, vascular occlusion, has an antidote when an HA product is involved.

Non-HA fillers — calcium hydroxylapatite, PLLA, and especially permanent fillers — do not have this escape route. They cannot simply be dissolved. If the result is unsatisfactory, correcting it may require time, further procedures, or in some cases surgery. If a serious complication develops, the absence of a quick reversal agent makes management harder. The very properties that make these fillers attractive — longevity, permanence — are the same properties that make them unforgiving when something goes wrong.

This reframes the "how long does it last?" question entirely. Longer-lasting is not straightforwardly better. A longer-lasting filler is also a longer-lasting mistake, and a permanent filler is a permanent one. For most people most of the time, the reversibility of HA fillers is a stronger argument than the durability of the alternatives — which is part of why HA fillers dominate the market and why thoughtful practice tends to favour them, particularly in higher-risk areas of the face.

The complications, briefly

Fillers share a set of possible complications. Common and minor: bruising, swelling, tenderness, lumps that settle. Less common but more significant: infection, persistent nodules, and granulomas (inflammatory lumps that can appear late). And the serious one, covered in depth elsewhere in this section: vascular occlusion, where filler obstructs a blood vessel, risking tissue death or — rarely, through the facial circulation — blindness.

The reason reversibility keeps returning is that it changes how each of these plays out. A nodule from an HA filler can be dissolved; a nodule from a permanent filler may not be. A vascular event with HA has an antidote; the same event with a non-reversible product does not. The complication list is similar across filler types; the consequences of being on that list differ enormously depending on what was injected.

What this means for thinking about fillers

The practical upshot is a shift in the questions worth asking. Not just "what will this cost and how long will it last?" but "what exactly is being injected, is it reversible, and does the person injecting it have the means to manage a complication if one occurs?" A setting using reversible HA filler, with hyaluronidase on hand and the skill to use it, is operating with a safety net. A setting using permanent filler, or unable to manage a vascular event, is not — regardless of how the result looks on the day.

None of this is an argument against fillers. It is an argument for asking the question that the marketing tends to skip, because it is the question that determines what happens on the worst day rather than the best one.

Practical takeaways

• "Filler" covers very different materials: hyaluronic acid (HA), biostimulatory and longer-lasting fillers (CaHA, PLLA), and permanent fillers.
• HA fillers are reversible — dissolvable with hyaluronidase — which is a major safety advantage, especially for vascular complications.
• Non-HA and permanent fillers are not readily reversible; their longevity is also what makes mistakes and complications harder to fix.
• "Longer-lasting" is not simply "better" — it also means a longer-lasting problem if the result or a complication is wrong.
• The questions that matter most are what exactly is being injected, whether it is reversible, and whether complications can be managed on site.

What this doesn't mean

This is not a claim that non-HA or longer-lasting fillers are illegitimate — they have appropriate uses in skilled hands. It is a point about emphasis: reversibility is the property that most determines how a bad outcome unfolds, and it deserves far more weight in any decision than the marketing usually gives it.

When to seek medical advice

After filler, seek urgent medical attention for severe or worsening pain, skin that blanches then turns dusky or mottled, or any change in vision — these can signal vascular occlusion, which is time-critical. Seek prompt advice for signs of infection (spreading redness, warmth, fever) or for new or persistent lumps. Always tell the clinician exactly what was injected and where, since management depends heavily on the filler type.

A closing thought

The cleverest thing the filler market does is direct attention to longevity and appearance — the best-case axes — and away from reversibility, the worst-case one. But the worst case is exactly where the difference between filler types becomes enormous. Ask what is going in, and whether it can come out. On a good day it changes nothing. On a bad day it changes everything.

Further reading and sources

• Hyaluronidase for dermal filler complications: applications, dosage and reversal — JMIR Dermatology
• Vascular occlusion following dermal filler injections: a systematic review (2025)
• British Association of Dermatologists — patient information on cosmetic procedures · British College of Aesthetic Medicine
• House of Commons Library — the regulation of non-surgical cosmetic procedures in England

Brand names are mentioned for identification only. The author has no commercial relationship with any manufacturer, and nothing here is an advertisement for, or recommendation to obtain, any medicine.